The lymph vessel network in mouse skin visualised with antibodies against the hyaluronan receptor LYVE-1

Immunobiology

Volumn 213, Issue 9-10, 2008, Pages 715-728

  Tripp, Christoph H ^a   Haid, Bernhard ^a   Flacher, Vincent ^a   Sixt, Michael ^b   Peter, Hannes ^c   Farkas, Julia ^c   Gschwentner, Robert ^d   Sorokin, Lydia ^e   Romani, Nikolaus ^a   Stoitzner, Patrizia ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Dendritic cell migration; Inflammation; Lymphatic vessels; Steady state migration

Indexed keywords

CD31 ANTIGEN; HYALURONIC ACID; IMIQUIMOD; LANGERIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN LYVE 1; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANASTOMOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; DERMIS; EAR; IMMUNOFLUORESCENCE; IN VIVO STUDY; LYMPH VESSEL; LYMPHATIC SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CULTURE; STEADY STATE; STIMULUS;

ANIMALS; ANTIBODIES; CELL MOVEMENT; DENDRITIC CELLS; GLYCOPROTEINS; LANGERHANS CELLS; LYMPHATIC VESSELS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SKIN;

EID: 52749084285     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2008.07.025     Document Type: Article

References (80)

1. Adema G.J., de Vries I.J., Punt C.J., and Figdor C.G. Migration of dendritic cell based cancer vaccines: in vivo veritas?. Curr. Opin. Immunol. 17 (2005) 170-174
2. Angel C.E., George E., Brooks A.E., Ostrovsky L.L., Brown T.L., and Dunbar P.R. Cutting edge: CD1a+ antigen-presenting cells in human dermis respond rapidly to CCR7 ligands. J. Immunol. 176 (2006) 5730-5734
3. Angeli V., Ginhoux F., Llodra J., Quemeneur L., Frenette P.S., Skobe M., Jessberger R., Merad M., and Randolph G.J. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24 (2006) 203-215
4. Banchereau J., and Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5 (2005) 296-306
5. Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., Jones M., and Jackson D.G. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144 (1999) 789-801
6. Bennett C.L., van Rijn E., Jung S., Inaba K., Steinman R.M., Kapsenberg M.L., and Clausen B.E. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169 (2005) 569-576
7. 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content. Eur. J. Nucl. Med. 30 (2003) 440-447
8. Böckle B.C., Sölder E., Kind S., Romani N., and Sepp N.T. DC-SIGN+ CD163+ macrophages expressing hyaluronan receptor LYVE-1 are located within chorion villi of the placenta. Placenta 29 (2008) 187-192
9. Breiteneder-Geleff S., Soleiman A., Kowalski H., Horvat R., Amann G., Kriehuber E., Diem K., Weninger W., Tschachler E., Alitalo K., and Kerjaschki D. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries - podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154 (1999) 385-394
10. + cells. J. Exp. Med. 204 (2007) 3147-3156
11. Chen L., Cursiefen C., Barabino S., Zhang Q., and Dana M.R. Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells. Invest. Ophthalmol. Vis. Sci. 46 (2005) 4536-4540
12. Cueni L.N., and Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J. Invest. Dermatol. 126 (2006) 2167-2177
13. Dadras S.S., Lange-Asschenfeldt B., Velasco P., Nguyen L., Vora A., Muzikansky A., Jahnke K., Hauschild A., Hirakawa S., Mihm M.C., and Detmar M. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod. Pathol. 18 (2005) 1232-1242
14. De Vries I.J.M., Krooshoop D.J.E.B., Scharenborg N.M., Lesterhuis W.J., Diepstra J.H.S., Van Muijen G.N.P., Strijk S.P., Ruers T.J., Boerman O.C., Oyen W.J.G., Adema G.J., Punt C.J.A., and Figdor C.G. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 63 (2003) 12-17
15. De Witte L., Nabatov A., Pion M., Fluitsma D., de Jong M.A., de Gruijl T., Piguet V., Van Kooyk Y., and Geijtenbeek T.B. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 13 (2007) 367-371
16. Dupasquier M., Stoitzner P., Van Oudenaren A., Romani N., and Leenen P.J.M. Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J. Invest. Dermatol. 123 (2004) 876-879
17. Dupasquier, M., Prens, E.P., Leenen, P.J.M., 2008. Dermal mononuclear phagocytes. In:, Saeland, S., (Ed.), Recent Advances in Skin Immunology. Research Signpost, Trivandrum, Kerala, India, ISBN: 978-81-308-0276-3.
18. Eberhard Y., Ortiz S., Ruiz L.A., Kuznitzky R., and Serra H.M. Up-regulation of the chemokine CCL21 in the skin of subjects exposed to irritants. BMC Immunol. 5 (2004) 7
19. Enk A.H., Becker J.C., and Schuler G. Immunotherapy of malignant melanoma - basic principles and novel therapeutic approaches. J. Dtsch. Dermatol. Ges. 4 (2006) 635-644
20. Fitzner N., Clauberg S., Essmann F., Liebmann J., and Kolb-Bachofen V. Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands. Clin. Vaccine Immunol. 15 (2008) 138-146
21. Gale N.W., Prevo R., Espinosa J., Ferguson D.J., Dominguez M.G., Yancopoulos G.D., Thurston G., and Jackson D.G. Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1. Mol. Cell. Biol. 27 (2007) 595-604
22. Geissmann F., Dieu-Nosjean M.C., Dezutter C., Valladeau J., Kayal S., Leborgne M., Brousse N., Saeland S., and Davoust J. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 196 (2002) 417-430
23. Gilboa E. Dendritic cell-based cancer vaccines. J. Clin. Invest. 117 (2007) 1195-1203
24. Ginhoux F., Collin M., Bogunovic M., Abel M., Leboef M., Helft J., Ochando J.C., Kissenpfennig A., Malissen B., Grisotto M., Snoeck H., Randolph G.J., and Merad M. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 204 (2007) 3133-3146
25. Giorgadze T.A., Zhang P.J., Pasha T., Coogan P.S., Acs G., Elder D.E., and Xu X. Lymphatic vessel density is significantly increased in melanoma. J. Cutan. Pathol. 31 (2004) 672-677
26. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., and Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194 (2001) 769-779
27. Heib V., Becker M., Warger T., Rechtsteiner G., Tertilt C., Klein M., Bopp T., Taube C., Schild H., Schmitt E., and Stassen M. Mast cells are crucial for early inflammation, migration of Langerhans cells and CTL responses following topical application of TLR7 ligand in mice. Blood 110 (2007) 946-953
28. Hemmi H., Yoshino M., Yamazaki H., Naito M., Iyoda T., Omatsu Y., Shimoyama S., Letterio J.J., Nakabayashi T., Tagaya H., Yamane T., Ogawa M., Nishikawa S., Ryoke K., Inaba K., Hayashi S., and Kunisada T. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-β1-dependent cells. Int. Immunol. 13 (2001) 695-704
29. Hofer S., Ivarsson L., Stoitzner P., Auffinger M., Rainer C., Romani N., and Heufler C. Adenosine slows migration of dendritic cells but does not affect other aspects of dendritic cell maturation. J. Invest. Dermatol. 121 (2004) 300-307
30. Holzmann S., Tripp C.H., Schmuth M., Janke K., Koch F., Saeland S., Stoitzner P., and Romani N. A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J. Invest. Dermatol. 122 (2004) 1165-1174
31. Huang S.S., Liu I.H., Smith T., Shah M.R., Johnson F.E., and Huang J.S. CRSBP-1/LYVE-l-null mice exhibit identifiable morphological and functional alterations of lymphatic capillary vessels. FEBS Lett. 580 (2006) 6259-6268
32. Jackson D.G. Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS 112 (2004) 526-538
33. Jiang A., Bloom O., Ono S., Cui W., Unternaehrer J., Jiang S., Whitney J.A., Connolly J., Banchereau J., and Mellman I. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27 (2007) 610-624
34. Johnson L.A., Clasper S., Holt A.P., Lalor P.F., Baban D., and Jackson D.G. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J. Exp. Med. 203 (2006) 2763-2777
35. Johnson L.A., Prevo R., Clasper S., and Jackson D.G. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J. Biol. Chem. 282 (2007) 33671-33680
36. Juhlin L., and Shelley W.B. New staining techniques for the Langerhans cell. Acta Derm. Venereol. (Stockholm) 57 (1977) 289-296
37. Kabashima K., Shiraishi N., Sugita K., Mori T., Onoue A., Kobayashi M., Sakabe J., Yoshiki R., Tamamura H., Fujii N., Inaba K., and Tokura Y. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am. J. Pathol. 171 (2007) 1249-1257
38. Kaplan D.H., Jenison M.C., Saeland S., Shlomchik W.D., and Shlomchik M.J. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23 (2005) 611-620
39. Kissenpfennig A., Henri S., Dubois B., Laplace-Builhé C., Perrin P., Romani N., Tripp C.H., Douillard P., Leserman L., Kaiserlian D., Saeland S., Davoust J., and Malissen B. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22 (2005) 643-654
40. Kriehuber E., Breiteneder-Geleff S., Groeger M., Soleiman A., Schoppmann S.F., Stingl G., Kerjaschki D., and Maurer D. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194 (2001) 797-808
41. Kuroshima S., Sawa Y., Kawamoto T., Yamaoka Y., Notani K., Yoshida S., and Inoue N. Expression of toll-like receptors 2 and 4 on human intestinal lymphatic vessels. Microvasc. Res. 67 (2004) 90-95
42. Lämmermann T., and Sixt M. The microanatomy of T-cell responses. Immunol. Rev. 221 (2008) 26-43
43. Lämmermann T., Bader B.L., Monkley S.J., Worbs T., Wedlich-Söldner R., Hirsch K., Keller M., Förster R., Critchley D.R., Fässler R., and Sixt M. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453 (2008) 51-55
44. Larsen C.P., Steinman R.M., Witmer-Pack M., Hankins D.F., Morris P.J., and Austyn J.M. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172 (1990) 1483-1493
45. Lenz A., Heine M., Schuler G., and Romani N. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J. Clin. Invest. 92 (1993) 2587-2596
46. Martín-Fontecha A., Sebastiani S., Höpken U.E., Uguccioni M., Lipp M., Lanzavecchia A., and Sallusto F. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198 (2003) 615-621
47. Mayerova D., Parke E.A., Bursch L.S., Odumade O.A., and Hogquist K.A. Langerhans cells activate naïve self-antigen specific CD8 T cells in the steady state. Immunity 21 (2004) 391-400
48. Merad M., Manz M.G., Karsunky H., Wagers A., Peters W., Charo I., Weissman I.L., Cyster J.G., and Engleman E.G. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3 (2002) 1135-1141
49. Methe H., Hess S., and Edelman E.R. Endothelial cell-matrix interactions determine maturation of dendritic cells. Eur. J. Immunol. 37 (2007) 1773-1784
50. Morse M.A., Coleman R.E., Akabani G., Niehaus N., Coleman D., and Lyerly H.K. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 59 (1999) 56-58
51. Nair S., McLaughlin C., Weizer A., Su Z., Boczkowski D., Dannull J., Vieweg J., and Gilboa E. Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation. J. Immunol. 171 (2003) 6275-6282
52. Ohl L., Mohaupt M., Czeloth N., Hintzen G., Kiafard Z., Zwirner J., Blankenstein T., Henning G., and Förster R. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21 (2004) 279-288
53. Ortner U., Inaba K., Koch F., Heine M., Miwa M., Schuler G., and Romani N. An improved isolation method for murine migratory cutaneous dendritic cells. J. Immunol. Methods 193 (1996) 71-79
54. Pierre P., Turley S.J., Gatti E., Hull M., Meltzer J., Mirza A., Inaba K., Steinman R.M., and Mellman I. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388 (1997) 787-792
55. + dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 204 (2007) 3119-3131
56. Prevo R., Banerji S., Ferguson D.J., Clasper S., and Jackson D.G. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276 (2001) 19420-19430
57. Randolph G.J., Angeli V., and Swartz M.A. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5 (2005) 617-628
58. Reddy S.T., van der Vlies A.J., Simeoni E., Angeli V., Randolph G.J., O'Neil C.P., Lee L.K., Swartz M.A., and Hubbell J.A. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat. Biotechnol. 25 (2007) 1159-1164
59. Romani N., Bhardwaj N., Pope M., Koch F., Swiggard W.J., O'Doherty U., Witmer-Pack M.D., Hoffman L., Schuler G., Inaba K., and Steinman R.M. Dendritic cells. In: Herzenberg L.A., Weir D.M., Herzenberg L., and Blackwell C. (Eds). Weir's Handbook of Experimental Immunology (1997), Blackwell Science, Oxford 156.1-156.14
60. Romani N., Ratzinger G., Pfaller K., Salvenmoser W., Stössel H., Koch F., and Stoitzner P. Migration of dendritic cells into lymphatics - the Langerhans cell example: routes, regulation, and relevance. Int. Rev. Cytol. 207 (2001) 237-270
61. Romani N., Ebner S., Tripp C.H., Flacher V., Koch F., and Stoitzner P. Epidermal Langerhans cells - changing views on their function in vivo. Immunol. Lett. 106 (2006) 119-125
62. Romani, N., Ebner, S., Flacher, V., Tripp, C.H., Heufler, C., Clausen, B.E., Stoitzner, P., 2008. Langerhans cells - dendritic cells of the epidermis and other epithelia. In: Saeland, S. (Ed.), Recent Advances in Skin Immunology. Research Signpost, Trivandrum, Kerala, India, ISBN: 978-81-308-0276-3.
63. Saeki H., Moore A.M., Brown M.J., and Hwang S.T. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162 (1999) 2472-2475
64. Sahni D., Robson A., Orchard G., Szydlo R., Evans A.V., and Russell-Jones R. The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status. J. Clin. Pathol. 58 (2005) 715-721
65. Shibaki A., Sato A., Vogel J.C., Miyagawa F., and Katz S.I. Induction of GVHD-like skin disease by passively transferred T cell receptor transgenic CD8+ T cells into keratin-14-ovalbumin transgenic mice. J. Invest. Dermatol. 123 (2004) 109-115
66. Shields J.D., Fleury M.E., Yong C., Tomei A.A., Randolph G.J., and Swartz M.A. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11 (2007) 526-538
67. Sixt M., Kanazawa N., Selg M., Samson T., Roos G., Reinhardt D.P., Pabst R., Lutz M.B., and Sorokin L.M. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22 (2005) 19-29
68. Steinman R.M., and Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99 (2002) 351-358
69. Stoitzner P., Pfaller K., Stössel H., and Romani N. A close-up view of migrating Langerhans cells in the skin. J. Invest. Dermatol. 118 (2002) 117-125
70. Stoitzner P., Holzmann S., McLellan A.D., Ivarsson L., Stössel H., Kapp M., Kämmerer U., Douillard P., Kämpgen E., Koch F., Saeland S., and Romani N. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J. Invest. Dermatol. 120 (2003) 266-274
71. Stoitzner P., Tripp C.H., Douillard P., Saeland S., and Romani N. Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation. J. Invest. Dermatol. 125 (2005) 116-125
72. Straume O., Jackson D.G., and Akslen L.A. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin. Cancer Res. 9 (2003) 250-256
73. Streilein J.W., and Bergstresser P.R. Langerhans cells: antigen presenting cells of the epidermis. Immunobiology 168 (1984) 285-300
74. Suzuki H., Wang B.H., Shivji G.M., Toto P., Amerio P., Tomai M.A., Miller R.L., and Sauder D.N. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J. Invest. Dermatol. 114 (2000) 135-141
75. Valladeau J., and Saeland S. Cutaneous dendritic cells. Semin. Immunol. 17 (2005) 273-283
76. Waithman J., Allan R.S., Kosaka H., Azukizawa H., Shortman K., Lutz M.B., Heath W.R., Carbone F.R., and Belz G.T. Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells. J. Immunol. 179 (2007) 4535-4541
77. Weinlich G., Heine M., Stössel H., Zanella M., Stoitzner P., Ortner U., Smolle J., Koch F., Sepp N.T., Schuler G., and Romani N. Entry into afferent lymphatics and maturation in situ of migrating cutaneous dendritic cells. J. Invest. Dermatol. 110 (1998) 441-448
78. Wilson N.S., Young L.J., Kupresanin F., Naik S.H., Vremec D., Heath W.R., Akira S., Shortman K., Boyle J., Maraskovsky E., Belz G.T., and Villadangos J.A. Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or toll-like receptor signaling. Immunol. Cell Biol. 86 (2008) 200-205
79. Yoshino M., Yamazaki H., Shultz L.D., and Hayashi S. Constant rate of steady-state self-antigen trafficking from skin to regional lymph nodes. Int. Immunol. 18 (2006) 1541-1548
80. Zaba L.C., Fuentes-Duculan J., Steinman R.M., Krueger J.G., and Lowes M.A. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J. Clin. Invest. 117 (2007) 2517-2525